Sun Finally Gains Control Of Taro As Founders Relent; Charts Out Aggressive Investment And Growth Plans
This article was originally published in PharmAsia News
Executive Summary
HYDERABAD - Bound by Israel's Supreme Court verdict earlier this month, drug firm Taro's founders - the Levitt and Moros families - have finally conceded management control of the 60-year old company that specializes in dermatology products to Sun Pharma - India's largest company by market capitalization
You may also be interested in...
A Deal A Month? After Dusa, India’s Sun Bags URL’s Generics Business As Takeda Keeps Colcrys
Sun Pharma continues its acquisition spree in the U.S. under new Chairman Israel Makov.
Will India’s Sun Rise On Stada? Bankers, Analysts Divided On Risks, Benefits
Stada’s financial woes may not be primary factors for Sun to bid but analysts reason there may be value accretive points.
Inside India’s Most Valued Pharma Company: Sun Pharma Chief Dilip Shanghvi Lays Out Future Growth Plans
Sun Pharma chief will look for opportunities in emerging markets, but buyouts will not be large.